Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Boerner

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical Breast Cancer|December 1, 2010
The role of phosphoinositide 3-kinase in breast cancer: an overviewPatricia M LoRusso, Scott A Boerner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Clinical development of vascular disrupting agents: what lessons can we learn from ASA404?Patricia M Lorusso, Scott A Boerner, Sally Hunsberger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
An overview of the optimal planning, design, and conduct of phase I studies of new therapeuticsPatricia M LoRusso, Scott A Boerner, Lesley Seymour
Clinical Lung Cancer|January 24, 2007
Non-rash skin toxicities associated with novel targeted therapiesMario E Lacouture, Scott A Boerner, Patricia M Lorusso
Journal of the National Cancer Institute|June 1, 2013
ResponseSally Hunsberger, Larry Rubinstein, Scott A Boerner, et al.
Cell Motility and the Cytoskeleton|March 29, 2002
Regulation of focal adhesion targeting and inhibitory functions of the FAK related protein FRNK using a novel estrogen receptor "switch"Karen H Martin, Scott A Boerner, J Thomas Parsons
Biochimica Et Biophysica Acta|December 30, 2006
Clinical experience of MEK inhibitors in cancer therapyDing Wang, Scott A Boerner, James D Winkler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Making the investigational oncology pipeline more efficient and effective: are we headed in the right direction?Patricia M LoRusso, Aparna B Anderson, Scott A Boerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Novel therapeutic inhibitors of the c-Met signaling pathway in cancerJoseph Paul Eder, George F Vande Woude, Scott A Boerner, et al.
Science (New York, N.Y.)|June 1, 2002
Integrin connections map: to infinity and beyondKaren H Martin, Jill K Slack, Scott A Boerner, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical Breast Cancer|December 1, 2010
The role of phosphoinositide 3-kinase in breast cancer: an overviewPatricia M LoRusso, Scott A Boerner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Clinical development of vascular disrupting agents: what lessons can we learn from ASA404?Patricia M Lorusso, Scott A Boerner, Sally Hunsberger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
An overview of the optimal planning, design, and conduct of phase I studies of new therapeuticsPatricia M LoRusso, Scott A Boerner, Lesley Seymour
Clinical Lung Cancer|January 24, 2007
Non-rash skin toxicities associated with novel targeted therapiesMario E Lacouture, Scott A Boerner, Patricia M Lorusso
Journal of the National Cancer Institute|June 1, 2013
ResponseSally Hunsberger, Larry Rubinstein, Scott A Boerner, et al.
Cell Motility and the Cytoskeleton|March 29, 2002
Regulation of focal adhesion targeting and inhibitory functions of the FAK related protein FRNK using a novel estrogen receptor "switch"Karen H Martin, Scott A Boerner, J Thomas Parsons
Biochimica Et Biophysica Acta|December 30, 2006
Clinical experience of MEK inhibitors in cancer therapyDing Wang, Scott A Boerner, James D Winkler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Making the investigational oncology pipeline more efficient and effective: are we headed in the right direction?Patricia M LoRusso, Aparna B Anderson, Scott A Boerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2009
Novel therapeutic inhibitors of the c-Met signaling pathway in cancerJoseph Paul Eder, George F Vande Woude, Scott A Boerner, et al.
Science (New York, N.Y.)|June 1, 2002
Integrin connections map: to infinity and beyondKaren H Martin, Jill K Slack, Scott A Boerner, et al.
Pageof 3